期刊文献+

类风湿关节炎22例死亡原因分析及文献复习 被引量:2

The causes of death in rheumatoid arthritis:a report of 22 cases and literature review
原文传递
导出
摘要 目的分析类风湿关节炎(RA)的死亡原因,提高对RA死因认识,加强治疗对策,提高防治水平。方法对22例RA患者死亡原因进行回顾性分析,并复习25年相关文献。结果22例RA患者的平均死亡年龄为(62±9)岁,平均病程(16±10)年。合并恶性肿瘤6例(宫颈癌、喉癌、结肠癌和多发性骨髓瘤各1例,胃癌2例),占27%;合并严重感染6例(肠道感染伴休克2例,肺部感染、胆囊炎伴胰腺炎、胆道感染和皮肤感染伴败血症各1例),为27%;肺间质病变伴感染致呼吸衰竭3例,占14%;脑血管病变3例,占14%;肾功能不全、心血管病变各1例,占9%;2例患者死在家中,原因不明,占9%。结论RA患者平均寿命缩短近10年,死亡的主要原因为合并感染和恶性肿瘤,其次为肺间质病变和脑血管病变。 Objective To promote the understanding of the causes of death in patients with rheuma-toid arthritis(RA)and to improve the prevention and therapy strategy of RA.Method Retrospectively analy-sis the death of twenty-two patients with RA and review the literatures in recent25years.Results Twenty two patients with RA,the average age of death was(62±9)years old,the mean duration was(16±10)years.Six27%cases died from malignancy(1carcinoma of cervix and larynx,cancer of colon,multiple myeloma,re-spectively;2gastric carcinoma),6(27%)from severe infection(2cases intestinal infection with shock,1pul-monary infection,1cholecystitis complicated with pancreatitis,1cholangitis and1skin infection with septice-ma,respectively),3(14%)died from respiratory failure attributed to interstitial lung disease and3(14%)from the cerebral vascular accident,respectively;1attributed to renal failure and1to cardiovascular accident,ac-count for about9%;the reason of death could not be identified in2cases(9%)becauses they died at home.Conclusion The life span of patients with RA has been reduced by10years.The causes of death are mainly infection and malignancy.Interstitial lung disease and cerebral vascular accident are also contribute.
出处 《中华风湿病学杂志》 CAS CSCD 2004年第6期342-345,共4页 Chinese Journal of Rheumatology
关键词 类风湿关节炎 死亡原因 预后 治疗 预防 Arthritis,rheumatoid Cause of death Mortality
  • 相关文献

参考文献23

  • 1许立德,陈韧,许敬才.类风湿关节炎11例的死亡原因分析[J].中华内科杂志,1996,35(7):485-486. 被引量:2
  • 2Keysor J, Sokka T, Krishnan E, et al. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol, 2004, 31:
  • 3Neva MH, Myllykangas R, Kautiainen H, et al. Mortality associated with cervical spine disorders:a population-based study of 1666 patients with rheumatoid arthritis who died in Finland in 1989. Rheumatology (Oxford), 2001, 40: 123-127.
  • 4Thomas E, Symmons DP, Brewster DH, et al. National study of causespecific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol, 2003, 30: 958-965.
  • 5Mau W, Zeidler H. Follow-up and prognosis in chronic polyarthritis. Versicherungsmedizin, 1999, 51:115-121.
  • 6Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford),1999, 38: 668-674.
  • 7Soderlin MK, Nieminen P, Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol, 1998, 25: 1895-1899.
  • 8Callahan LF, Pincus T, Huston JW, et al. Measures of activity and damage in rheumatoid arthritis:depiction of changes and prediction of mortality over five years. Arthritis Care Res, 1997, 10:381-394.
  • 9Okuda Y, Takasugi K, Oyama T, et al. Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis, 1997, 56: 535-541.
  • 10Maiden N, Capell HA, Madhok R, et al. Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?Ann Rheum Dis, 1999, 58: 525-529.

共引文献1

同被引文献25

  • 1曹虹,贡树基,赵卫,仲华,张文炳.人微小病毒B19感染的研究进展[J].微生物学通报,2007,34(2):332-338. 被引量:19
  • 2Young A, Koduri G, Batley M, et al. Mortality in rheumatoidarthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford), 2006, 46: 350-357.
  • 3Doran M, Crowson C, Pond G, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthri- tis Rheum, 2002, 46: 2287-2293.
  • 4Young C, Adamson TI, Vaughan J, et al. Immunohistological characterization of synovial membrane lymphecytes in rheumatoid arthritis. Arthritis Rheum, 1984, 27: 32-39.
  • 5Sang KG, KoLluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease: determinants of physiologic and radiographic ab- normalities. Arthritis Rheum, 1996, 39: 1711-1719.
  • 6O'DeU J, Gilg J, Palmer W, et al. Pneumococcal vaccine in rheumatoid arthritis. Decreased response while on methotrexate. J Clin Rheumatol, 1996, 2:59-63.
  • 7Goodson N, Marks J, Lunt M, et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis, 2005, 64: 1595-1601.
  • 8Morgan $L, Baggott JE, Lee JY, eta]. Folic acid supplementa- tion prevents deficient blood folate levels and hyperhomocys- teinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease pre- vention. J Rheumatol, 1998, 25: 441-446.
  • 9Laszerini PE, Capecchi PL, Bisogno S, et al. Reduction in plas- ma homocysteine level in patients with rheumatoid arthritis given pulsed g]ucocorticoid treatment. Ann Rheum Dis, 2003, 62: 694-695.
  • 10Klimiuk PA, $ierakowski S, Domyslawska I, et al. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol, 2009, 38: 439-444.

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部